Clinical Trial Update: A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency [Phase 2]

View source ↗

Summary

A Phase 2 clinical study is assessing Sutacimig in participants with congenital Factor VII deficiency and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Factor Vii Deficiency

Drugs mentioned

• Sutacimig

Snippet

Sponsor: Hemab ApS | Conditions: Congenital Factor VII Deficiency | Phase 2 | Status: RECRUITING